Inventor · disambiguated record
Oliver Denk
Also filed as: DENK OLIVER
9 granted patents·7 pending applications·9 citations·filing 2016–2025
82Inventor score
Top patents by PatentIndex Score
16 records- 0188US11701403B2Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS)BREATH THERAPEUTICS GMBH·Filed 2022·Granted Jul 18, 2023·1 cites·32 claims
- 0288US11484566B2Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS)BREATH THERAPEUTICS GMBH·Filed 2019·Granted Nov 1, 2022·4 cites·35 claims
- 0386US11419819B2Inhalable compositions for use in the treatment of pulmonary diseasesBREATH THERAPEUTICS GMBH·Filed 2019·Granted Aug 23, 2022·2 cites·32 claims
- 0485US10857198B2Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejectionBREATH THERAPEUTICS GMBH·Filed 2016·Granted Dec 8, 2020·2 cites·15 claims
- 0581US12263247B2Inhalable compositions for use in the treatment of pulmonary diseasesBREATH THERAPEUTICS GMBH·Filed 2023·Granted Apr 1, 2025·0 cites·27 claims
- 0681US2025090625A1Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (bos)BREATH THERAPEUTICS GMBH·Filed 2024·Application pending·0 cites
- 0780US12178843B2Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS)BREATH THERAPEUTICS GMBH·Filed 2023·Granted Dec 31, 2024·0 cites·27 claims
- 0877US11890376B2Inhalable compositions for use in the treatment of pulmonary diseasesBREATH THERAPEUTICS GMBH·Filed 2022·Granted Feb 6, 2024·0 cites·29 claims
- 0977US2024016885A1Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejectionBREATH THERAPEUTICS GMBH·Filed 2023·Application pending·0 cites
- 1072US2025241855A1Inhalable compositions for use in the treatment of pulmonary diseasesBREATH THERAPEUTICS GMBH·Filed 2025·Application pending·0 cites
- 1170US2023301914A1Pharmaceutical compositions in lyophilized formBREATH THERAPEUTICS GMBH·Filed 2023·Application pending·0 cites
- 1269US11744872B2Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejectionBREATH THERAPEUTICS GMBH·Filed 2020·Granted Sep 5, 2023·0 cites·21 claims
- 1366US2025248934A1Inhalable compositions comprising macrocyclic immunosuppressantsBREATH THERAPEUTICS GMBH·Filed 2025·Application pending·0 cites
- 1460US2021244664A1Pharmaceutical compositions in lyophilized formBREATH THERAPEUTICS GMBH·Filed 2019·Application pending·0 cites
- 1555US12303593B2Inhalable compositions comprising macrocyclic immunosuppressantsBREATH THERAPEUTICS GMBH·Filed 2019·Granted May 20, 2025·0 cites·31 claims
- 1651US2023000766A1Process for the preparation of dispersions comprising inhalable immunosuppressive active ingredientsZAMBON SPA·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →